|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
2seventy Bio, Inc. (TSVT) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
51,961,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0 - $0 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile 2seventy bio is a cell and gene therapy company focused on the research, development, and commercialization of treatments for cancer. Co.'s approach combines its capability in T cell engineering technology and lentiviral vector gene delivery approaches, experience in research, development, and manufacturing of cell therapies and a suite of technologies that can be selectively deployed to develop targeted cellular therapies for patients with cancer. Co. is developing various preclinical and clinical programs in oncology and, together with its partner Bristol-Myers Squibb, delivering idecabtagene vicleucel to multiple myeloma patients in the U.S. following approval by the FDA.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
817,377 |
817,377 |
2,021,033 |
2,021,033 |
Total Buy Value |
$4,103,042 |
$4,103,042 |
$11,231,670 |
$11,231,670 |
Total People Bought |
2 |
2 |
4 |
4 |
Total Buy Transactions |
4 |
4 |
8 |
8 |
Total Shares Sold |
15 |
135,320 |
177,754 |
231,800 |
Total Sell Value |
$74 |
$523,073 |
$768,628 |
$1,472,786 |
Total People Sold |
1 |
4 |
4 |
5 |
Total Sell Transactions |
1 |
7 |
13 |
32 |
End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Gregory Philip D |
Chief Scientific Officer |
|
2023-01-11 |
4 |
S |
$10.63 |
$11,436 |
D/D |
(1,076) |
99,518 |
|
- |
|
Baird William D Iii |
Chief Financial Officer |
|
2023-01-11 |
4 |
S |
$10.63 |
$11,446 |
D/D |
(1,077) |
78,797 |
|
- |
|
Leschly Nick |
President and CEO |
|
2023-01-11 |
4 |
S |
$10.63 |
$21,533 |
D/D |
(2,026) |
534,393 |
|
- |
|
Baird William D Iii |
Chief Financial Officer |
|
2023-01-09 |
4 |
S |
$10.33 |
$33,298 |
D/D |
(3,222) |
79,874 |
|
- |
|
Heffron Nicola |
Chief Operating Officer |
|
2023-01-09 |
4 |
S |
$10.33 |
$6,035 |
D/D |
(584) |
89,370 |
|
- |
|
Leschly Nick |
President and CEO |
|
2023-01-09 |
4 |
S |
$10.33 |
$30,787 |
D/D |
(2,979) |
543,006 |
|
- |
|
Gregory Philip D |
Chief Scientific Officer |
|
2023-01-09 |
4 |
S |
$10.33 |
$39,210 |
D/D |
(3,794) |
100,594 |
|
- |
|
Heffron Nicola |
Chief Operating Officer |
|
2022-12-05 |
4 |
S |
$15.43 |
$4,198 |
D/D |
(272) |
89,954 |
|
- |
|
Heffron Nicola |
Chief Operating Officer |
|
2022-11-21 |
4 |
S |
$13.97 |
$107,527 |
D/D |
(7,697) |
90,226 |
|
- |
|
Gregory Philip D |
Chief Scientific Officer |
|
2022-08-05 |
4 |
S |
$16.23 |
$39,072 |
D/D |
(2,407) |
104,388 |
|
- |
|
Baird William D Iii |
Chief Financial Officer |
|
2022-08-05 |
4 |
S |
$16.23 |
$67,397 |
D/D |
(4,152) |
83,096 |
|
- |
|
Leschly Nick |
President and CEO |
|
2022-08-05 |
4 |
S |
$16.23 |
$89,263 |
D/D |
(5,499) |
545,985 |
|
- |
|
Gregory Philip D |
Chief Scientific Officer |
|
2022-07-15 |
4 |
S |
$13.81 |
$32,660 |
D/D |
(2,365) |
106,795 |
|
- |
|
Leschly Nick |
President and CEO |
|
2022-07-15 |
4 |
S |
$13.81 |
$74,629 |
D/D |
(5,404) |
551,484 |
|
- |
|
Baird William D Iii |
Chief Financial Officer |
|
2022-07-15 |
4 |
S |
$13.81 |
$56,344 |
D/D |
(4,080) |
87,248 |
|
- |
|
Leschly Nick |
President and CEO |
|
2022-03-17 |
4/A |
B |
$12.20 |
$4,500,055 |
D/D |
368,857 |
556,888 |
0.01 |
- |
|
Leschly Nick |
President and CEO |
|
2022-03-17 |
4 |
A |
$12.20 |
$4,500,055 |
D/D |
368,857 |
556,888 |
|
- |
|
Baird William D Iii |
Chief Financial Officer |
|
2022-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
33,750 |
91,328 |
|
- |
|
Heffron Nicola |
Chief Operating Officer |
|
2022-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
42,500 |
97,923 |
|
- |
|
Gregory Philip D |
Chief Scientific Officer |
|
2022-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
47,500 |
109,160 |
|
- |
|
Leschly Nick |
President and CEO |
|
2022-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
133,500 |
690,388 |
|
- |
|
Baird William D Iii |
Chief Financial Officer |
|
2022-02-17 |
4 |
S |
$14.78 |
$6,311 |
D/D |
(427) |
57,578 |
|
- |
|
Heffron Nicola |
Chief Operating Officer |
|
2022-02-07 |
4 |
S |
$16.01 |
$26,194 |
D/D |
(1,636) |
55,423 |
|
- |
|
Heffron Nicola |
Chief Operating Officer |
|
2022-02-04 |
4 |
S |
$15.41 |
$7,198 |
D/D |
(467) |
57,059 |
|
- |
|
Gregory Philip D |
Chief Scientific Officer |
|
2022-01-07 |
4 |
S |
$23.91 |
$34,714 |
D/D |
(1,452) |
61,660 |
|
- |
|
86 Records found
|
|
Page 3 of 4 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|